| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
At Fitness Connection, we exist to change lives every day. We are in the business because we truly believe that what we do can make the world a better place. That is why we chose to make a healthier lifestyle more accessible by providing a high-quality experience at a value.
American Academy of CME is a Skillman, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Central Illinois Neuro Health Sciences is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bloomington, IL. To find more information about Central Illinois Neuro Health Sciences, please visit www.cinhs.com
Correctional Healthcare Management is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.